vs

Side-by-side financial comparison of Ceribell, Inc. (CBLL) and TRUSTCO BANK CORP N Y (TRST). Click either name above to swap in a different company.

TRUSTCO BANK CORP N Y is the larger business by last-quarter revenue ($49.5M vs $24.8M, roughly 2.0× Ceribell, Inc.). TRUSTCO BANK CORP N Y runs the higher net margin — 32.9% vs -54.6%, a 87.4% gap on every dollar of revenue.

Ceribell, Inc. develops and commercializes innovative portable neurodiagnostic medical devices, focused on rapid non-invasive electroencephalogram (EEG) solutions for seizure detection. Its core products serve hospital emergency departments, intensive care units, and long-term care facilities, with primary markets across North America and ongoing global expansion efforts.

TRUSTCO BANK CORP N Y is a regional U.S. financial holding company that provides a full suite of retail and commercial banking products and services, including personal deposit accounts, mortgage loans, small business financing, and wealth management solutions. It primarily operates across New York, Florida, and several other U.S. states, serving individual consumers and small business client segments.

CBLL vs TRST — Head-to-Head

Bigger by revenue
TRST
TRST
2.0× larger
TRST
$49.5M
$24.8M
CBLL
Higher net margin
TRST
TRST
87.4% more per $
TRST
32.9%
-54.6%
CBLL

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
CBLL
CBLL
TRST
TRST
Revenue
$24.8M
$49.5M
Net Profit
$-13.5M
$16.3M
Gross Margin
87.3%
Operating Margin
-58.9%
Net Margin
-54.6%
32.9%
Revenue YoY
Net Profit YoY
14.1%
EPS (diluted)
$-0.35

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CBLL
CBLL
TRST
TRST
Q1 26
$49.5M
Q4 25
$24.8M
$48.2M
Q3 25
$22.6M
$47.8M
Q2 25
$21.2M
$46.6M
Q1 25
$20.5M
$45.3M
Q4 24
$43.3M
Q3 24
$17.2M
$43.6M
Q2 24
$43.4M
Net Profit
CBLL
CBLL
TRST
TRST
Q1 26
$16.3M
Q4 25
$-13.5M
$15.6M
Q3 25
$-13.5M
$16.3M
Q2 25
$-13.6M
$15.0M
Q1 25
$-12.8M
$14.3M
Q4 24
$11.3M
Q3 24
$-10.4M
$12.9M
Q2 24
$12.6M
Gross Margin
CBLL
CBLL
TRST
TRST
Q1 26
Q4 25
87.3%
Q3 25
88.3%
Q2 25
88.1%
Q1 25
87.9%
Q4 24
Q3 24
87.3%
Q2 24
Operating Margin
CBLL
CBLL
TRST
TRST
Q1 26
Q4 25
-58.9%
43.7%
Q3 25
-64.8%
44.6%
Q2 25
-70.5%
42.3%
Q1 25
-69.3%
41.3%
Q4 24
34.0%
Q3 24
-57.8%
38.8%
Q2 24
37.9%
Net Margin
CBLL
CBLL
TRST
TRST
Q1 26
32.9%
Q4 25
-54.6%
32.3%
Q3 25
-59.6%
34.0%
Q2 25
-64.4%
32.3%
Q1 25
-62.4%
31.5%
Q4 24
26.0%
Q3 24
-60.6%
29.5%
Q2 24
28.9%
EPS (diluted)
CBLL
CBLL
TRST
TRST
Q1 26
Q4 25
$-0.35
$0.85
Q3 25
$-0.37
$0.86
Q2 25
$-0.38
$0.79
Q1 25
$-0.36
$0.75
Q4 24
$0.59
Q3 24
$-1.85
$0.68
Q2 24
$0.66

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CBLL
CBLL
TRST
TRST
Cash + ST InvestmentsLiquidity on hand
$159.3M
Total DebtLower is stronger
$112.9M
Stockholders' EquityBook value
$155.3M
$670.9M
Total Assets
$195.8M
$6.5B
Debt / EquityLower = less leverage
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CBLL
CBLL
TRST
TRST
Q1 26
Q4 25
$159.3M
$730.4M
Q3 25
$168.5M
$695.6M
Q2 25
$177.4M
$713.6M
Q1 25
$182.7M
$756.1M
Q4 24
$641.8M
Q3 24
$14.1M
$523.0M
Q2 24
$536.1M
Total Debt
CBLL
CBLL
TRST
TRST
Q1 26
$112.9M
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Stockholders' Equity
CBLL
CBLL
TRST
TRST
Q1 26
$670.9M
Q4 25
$155.3M
$686.6M
Q3 25
$164.1M
$692.0M
Q2 25
$172.2M
$692.8M
Q1 25
$180.9M
$687.8M
Q4 24
$676.3M
Q3 24
$-136.0M
$669.0M
Q2 24
$655.2M
Total Assets
CBLL
CBLL
TRST
TRST
Q1 26
$6.5B
Q4 25
$195.8M
$6.4B
Q3 25
$199.5M
$6.3B
Q2 25
$207.7M
$6.3B
Q1 25
$213.5M
$6.3B
Q4 24
$6.2B
Q3 24
$47.1M
$6.1B
Q2 24
$6.1B
Debt / Equity
CBLL
CBLL
TRST
TRST
Q1 26
0.17×
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CBLL
CBLL
TRST
TRST
Operating Cash FlowLast quarter
$-10.8M
Free Cash FlowOCF − Capex
$-11.0M
FCF MarginFCF / Revenue
-44.2%
Capex IntensityCapex / Revenue
0.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-41.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CBLL
CBLL
TRST
TRST
Q1 26
Q4 25
$-10.8M
$57.6M
Q3 25
$-11.1M
$12.8M
Q2 25
$-7.5M
$27.1M
Q1 25
$-11.4M
$1.3M
Q4 24
$59.4M
Q3 24
$16.5M
Q2 24
$18.7M
Free Cash Flow
CBLL
CBLL
TRST
TRST
Q1 26
Q4 25
$-11.0M
$45.7M
Q3 25
$-11.5M
$10.0M
Q2 25
$-7.6M
$24.9M
Q1 25
$-11.6M
$-3.3M
Q4 24
$54.6M
Q3 24
$15.6M
Q2 24
$17.6M
FCF Margin
CBLL
CBLL
TRST
TRST
Q1 26
Q4 25
-44.2%
95.0%
Q3 25
-50.8%
20.9%
Q2 25
-35.9%
53.5%
Q1 25
-56.4%
-7.2%
Q4 24
126.0%
Q3 24
35.7%
Q2 24
40.5%
Capex Intensity
CBLL
CBLL
TRST
TRST
Q1 26
Q4 25
0.7%
24.6%
Q3 25
1.6%
5.9%
Q2 25
0.3%
4.5%
Q1 25
0.7%
10.0%
Q4 24
11.3%
Q3 24
2.1%
Q2 24
2.6%
Cash Conversion
CBLL
CBLL
TRST
TRST
Q1 26
Q4 25
3.70×
Q3 25
0.79×
Q2 25
1.80×
Q1 25
0.09×
Q4 24
5.27×
Q3 24
1.28×
Q2 24
1.49×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CBLL
CBLL

Products$18.8M76%
Subscription$6.0M24%

TRST
TRST

Net Interest Income$44.7M90%
Noninterest Income$4.8M10%

Related Comparisons